Erik L. Ridley

Moderate Complexity Test
AACC lobbies against greater regulation of lab-developed tests
The Verifying Accurate Leading-edge IVCT Development (VALID) Act would limit the availability of laboratory-developed tests, decreasing patient access to these diagnostic tools, the AACC said. Often created when there is no FDA-approved commercial test available, these tests are frequently used to diagnose rare conditions -- such as genetic abnormalities in children -- or to respond to emerging health threats such as COVID-19, according to the association.
May 24, 2022
2020 07 01 22 14 2802 Washington Dc Capitol 400
Alzheimer's
Quest publishes Alzheimer’s report, unveils blood test
The report, called "The Coming Alzheimer's Disease Healthcare Revolution: U.S. Physician and Adult Perspectives on the Future of Diagnostics and Treatment," found that 66% of physicians believe that "we are on the precipice of groundbreaking new treatment options" for Alzheimer's disease, according to Quest.
May 3, 2022
2019 07 15 19 08 6013 Amyloid Plaque Alzheimer 400
Pancreatic Cancer
AI spots patients at elevated risk for pancreatic cancer
A team of researchers from the U.S. and Denmark used electronic health record (EHR) data from the Danish National Patient Registry to train their algorithm and then tested it on electronic medical records from Mass General Brigham Health Care System in Boston. Their model proved to be highly accurate for predicting patients at high risk for pancreatic cancer on large datasets from both countries.
April 8, 2022
2020 03 12 20 41 0454 Computer Brain Circuit Ai 400
Infectious
Blue Cross sues GS Labs over COVID test payments
Filed in the U.S. District Court of Minnesota, the complaint alleges that GS Labs defrauded Blue Cross by submitting tens of thousands of claims using inflated cash prices over the past year.
February 28, 2022
2020 07 22 15 50 6516 Lawsuit 400
Health Topics
AI mines CT, lab results to predict COVID-19 severity
A team of researchers led by Yibai Xiong and Yan Ma of the China Academy of Chinese Medical Sciences trained three different machine-learning models to identify severe COVID-19 cases at admission based on 23 variables, including chest CT results, one clinical feature, and 21 laboratory values. In testing, the best-performing algorithm yielded an area under the curve (AUC) of 0.970.
February 22, 2022
2020 10 09 22 54 5002 Covid 19 Data Ai Information 400
Collaboration
BD buys flow cytometry technology firm Cytognos
In addition to use in MRD applications, the Cytognos technology can also be utilized in immune monitoring research for blood diseases. Terms of the deal were not disclosed.
January 31, 2022
2019 08 20 21 56 4986 Becton Aacc 2019 400
510(k)
FDA clears 1st prostate pathology AI software application
Designed to serve as an adjunct to pathologist review of digitized prostate biopsy images, Paige Prostate identifies areas of interest on the images that contain the highest likelihood of cancer. Pathologists can then further review the AI findings if they had not identified these areas of concern on their initial evaluation, according to the FDA.
September 20, 2021
2019 02 13 19 24 5396 Fda Logo V2 400
Validation
AI can lend a hand in diagnosis, prognosis of oral SCC
After reviewing published studies in the literature on the use of AI with pathology and radiology images in patients with oral SCC, researchers from the University of Hong Kong concluded that the technology yielded good classification accuracy.
August 18, 2021
2021 08 18 23 12 2135 Computer Ai Artificial Illustration 400
Health Topics
FDA warns of false positives from SARS-CoV-2 antigen tests
These false positive findings can occur many reasons, for example when users do not follow instructions for the tests, according to the FDA. The FDA offered several recommendations for clinical laboratory staff and healthcare providers:
November 2, 2020
2016 09 02 09 36 05 93 Fda Logo V2 400
Clinical Trial
3D-printed swabs make the grade for COVID-19 testing
A multidisciplinary research team led by first author Cody Callahan of BIDMC's department of radiology and senior author Dr. Ramy Arnaout, PhD, of the institution's Clinical Microbiology Laboratories investigated over 150 swab designs and nearly 50 materials in a multiphase analysis that included preclinical evaluation, assessment of production considerations, and field testing in a clinical trial.
June 11, 2020
2020 06 02 22 19 7693 Coronavirus Swab Ppe 400
Page 1 of 2
Next Page
Top Stories
Proscia Embeddings
Artificial Intelligence
Proscia launches pathology AI model toolkit
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
Crispr Cas9 Gene Editing
Emerging Technology
CRISPR patent decisions could trigger waves globally
Doctor Patient Consult
Pathology and AI
Ibex survey indicates some comfort with AI in cancer diagnostics
Olfactory Bulb Brain Cr Social
Pathology and AI
Pathologists detect microplastics in human brain tissue
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Home
Proscia launches pathology AI model toolkit
By Liz Carey
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
October 2, 2024
Proscia Embeddings
CRISPR patent decisions could trigger waves globally
By LabPulse.com staff writers
Canceling a pair of patents in Europe will affect a broad network of biotech companies that have bought and sold the rights to pursue gene-slicing research, according to a September 25 report published in MIT Technology Review.
September 30, 2024
Crispr Cas9 Gene Editing
Ibex survey indicates some comfort with AI in cancer diagnostics
By LabPulse.com staff writers
A recent survey reports that more than 50% of U.S. adults have received an incorrect medical test result for themselves or a loved one. Additionally, 60% would trust artificial intelligence (AI) supporting medical diagnoses.
September 25, 2024
Doctor Patient Consult
Pathologists detect microplastics in human brain tissue
By Will Morton
Pathologists have detected microplastics in the olfactory bulb brain tissues of eight deceased individuals in Sao Paulo, highlighting the need for further research about their effects on human health, reports a study published in JAMA Network Open.
September 25, 2024
Olfactory Bulb Brain Cr Social
NIH establishes pandemic preparedness research network
By LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Infectious Diseases Research Social
CDC adds commercial lab contracts for infectious disease, bird flu testing
By Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
Multiregional clinical trial data on FDA watch for U.S. applicability
By LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Fda Sign Dc Social
Seegene launches 3rd RUO mpox assay
By LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
3 D Monkeypox Infecting Cell Social
Hospital labs targeted in proposed Calif. hospital licensing regulations
By Liz Carey
Proposed changes could require some hospitals to materially alter their current operations, according to advisers.
September 11, 2024
Regulation Wheel Social
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Dna Sequencing Data Analysis Social
ADLM releases guidance for blood lipid assessment, lipoprotein testing
By LabPulse.com staff writers
Document outlines recommendations for standardizing clinical lipid testing workflows.
September 4, 2024
Blood Test Samples Lab Social
Seegene, Springer Nature launch PCR innovation program
By LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Research Money Social
Page 1 of 125
Next Page